Evidence map›Paper›PMID 42216761›Full record

ArticleNucleic acids research2026

A dynamic search mechanism enables APE1 to identify AP-sites in DNA.

Kaitlin M DeHart, Peyton N Oden, Tyler M Weaver, Matthew A Schaich, Bennett Van Houten, Bret D Freudenthal

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kaitlin M DeHartDepartment of Biochemistry and Molecular Biology, Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, United States.ORCID 0009-0009-0228-8582
Peyton N OdenDepartment of Biochemistry and Molecular Biology, Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, United States.ORCID 0009-0005-8506-2028
Tyler M WeaverDepartment of Biochemistry and Molecular Biology, Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, United States.ORCID 0000-0002-5138-7140
Matthew A SchaichHillman Cancer Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, United States.
Bennett Van HoutenHillman Cancer Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, United States.ORCID 0000-0002-4009-2478
Bret D FreudenthalDepartment of Biochemistry and Molecular Biology, Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, United States.ORCID 0000-0003-1449-4710

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
Supplement to NIH Award 2 R35GM128562-06R35GM128562 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Bret D Freudenthal · 2018 to 2026
$4.2M
Dynamics of oxidative DNA demethylation from duplex DNA to chromatinK99ES036599 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHAICH, MATTHEW ALLEN · 2025 to 2025
$127k
National Institute of Enviornmental Sciences K99ES036599National Institute of Enviornmental Sciences R35ES031638National Institute of Enviornmental Sciences S10OD032158NCI NIH HHS P30 CA168524NIEHS NIH HHS K99 ES036599NIGMS NIH HHS R35 GM128562NIGMS NIH HHS R35GM128562
6 · The paper itself

Abstract

Apurinic/apyrimidinic (AP) sites are among the most frequent DNA lesions, arising thousands of times per cell each day. These lesions threaten genomic stability and, if left unrepaired, can lead to mutagenesis and disease. The base excision repair enzyme Apurinic/Apyrimidinic Endonuclease I (APE1) initiates repair by cleaving DNA at AP-sites, yet how APE1 efficiently identifies these lesions within vast excesses of undamaged DNA has remained unclear. Using single-molecule imaging, we show that APE1 employs a dynamic search strategy that integrates one-dimensional (1D) and three-dimensional (3D) diffusion to rapidly scan DNA. On non-damaged DNA, APE1 undergoes rapid diffusion, enabling efficient interrogation of large genomic regions within a single binding event. Upon encountering an AP-site, APE1 transitions from a mobile search state to a stable lesion-bound complex that remains localized at the site of damage. Experiments with APE1 variants further reveal that the intrinsically disordered N-terminal domain promotes 1D diffusion, residue R177 stabilizes APE1 at the AP-site after recognition, and catalytic residues D210 and E96 facilitate enzyme release following cleavage. Together, these findings define how APE1 balances rapid genome surveillance with stable lesion engagement and timely release. More broadly, this work provides a mechanistic framework for how DNA repair enzymes efficiently locate and process rare lesions embedded within excess undamaged DNA.

Indexed as

DNADNA-(Apurinic or Apyrimidinic Site) LyaseDNA DamageDNA RepairExcision RepairHumansProtein BindingSingle Molecule ImagingAPEX1 protein, humanDNADNA-(Apurinic or Apyrimidinic Site) Lyase

Identifiers

PMID42216761
PMCPMC13221653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.